![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, April 19, 2012 12:18:22 PM
http://finance.yahoo.com/news/sage-labs-creates-first-tissue-110000062.html
SIAL announces that it has achieved (using zinc fingers, of course!) the first tissue-specific conditional knockout in rats.
(if you can do it in rats, you can do it in silkworms. And with ZFs, wherever you can do a knock out, you can also do an insertion.)
One powerful application of this is to be able to up (or down) regulate a gene in a particular tissue when such regulation would cause problems if it occurred in additional tissues. This greatly extends the ability of KBLB to modify the silkworms and the silk in a planned manner.
(I wonder whether the large number of insertions made in the recent round of KBLB's ZF GMs is, in part, to utilize this new ability to regulate/add genes in specific tissues? This is EXACTLY the sort of thing you'd do, for example, to increase the level of a particular silk protein in the silk)
The "tissue specific" is a VERY big deal: when you are inserting genes from one species to another, sometimes they'll do what you want in one tissue, but cause problems in another, so the ideal is to get it expressed only in the tissue(s) you want it to be.
This ability means that some potential problems KBLB MIGHT encounter could be readily solved IF they should occur.
There are abundant tools to determine if something went wrong due to the addition of a transgene, where it did (expressed sequence tags, gene expression array chips, etc). Now any problems due to expression in the wrong tissues (one of the likeliest of potential problems when adding transgenes) can be readily solved with SIAL's zinc fingers.
There is very little question, IMHO, that KBLB will ultimately succeed, primarily due to the power of zinc fingers. (this is something very new and still not generally appreciated - KBLB might well be the first company to get it the recognition it deserves).
And, of course, the ability is not just for solving problems, but greatly adds to the range and power of what KBLB will be able to do with silkworms.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM